What is the current stock price of bioAffinity Technologies, Inc. (BIAFW)?

As of the latest market data, bioAffinity Technologies, Inc. (BIAFW) is trading at $0.18. The stock has seen a loss of -10.04% today.

Does bioAffinity Technologies, Inc. (BIAFW) pay a dividend?

Based on current data, bioAffinity Technologies, Inc. does not have a confirmed active dividend policy.

What is the market cap of bioAffinity Technologies, Inc.?

The current market capitalization of bioAffinity Technologies, Inc. (BIAFW) is approximately unavailable.

BIAFW

bioAffinity Technologies, Inc.·Healthcare

0.18

10.045%(−0.02)

Close Price

0.22

22.667%(+0.04)

Pre-Market

Last Updated: — ET

52W L: $0.1852W H: $0.47

Company Profile

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

IPO Date

2022-09-01

Beta

-1.19

Websitewww.bioaffinitytech.com↗